Clinical Trial Update: Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances [Phase 4]

View source ↗

Summary

This Phase IV trial update reports the completion of a study evaluating the safety and efficacy of pramipexole for restless legs syndrome associated with mood d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Restless Legs Syndrome

Drugs mentioned

• Mirapex (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome, Depression | Phase 4 | Status: COMPLETED